Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

7.8K
This protocol describes xenograft and orthotopic mouse models of human thyroid tumorigenesis as a platform to test microRNA-based inhibitor treatments. This approach is ideal to study the function of non-coding RNAs and their potential as new therapeutic...
7.8K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

6.4K
Here, we show therapeutic potential of anti-angiogenic tumor-associated neutrophils after their transfer into tumor-bearing mice. This protocol can be used to manipulate neutrophil activity ex vivo and to subsequently evaluate their functionality in vivo in developing tumors. It is an appropriate model for studying potential neutrophil-based...
6.4K
MicroRNAs01:22

MicroRNAs

24.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K
Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo09:48

Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo

14.4K
GABAergic presynaptic inhibition is a powerful inhibitory mechanism in the spinal cord important for motor and sensory signal integration in spinal cord networks. Underlying primary afferent depolarization can be measured by recording of dorsal root potentials (DRP). Here we demonstrate a method of in vivo recording of DRP in...
14.4K
MicroRNA-Mediated Inhibition of Excitatory Postsynaptic Currents in Mouse Hippocampal Slices04:27

MicroRNA-Mediated Inhibition of Excitatory Postsynaptic Currents in Mouse Hippocampal Slices

495
This video demonstrates microRNA-mediated inhibition of excitatory synaptic currents in mouse hippocampal brain slices. The CA3 neurons were infected with a recombinant viral vector harboring a construct for expressing a fluorescent reporter, a light-activated membrane channel, and a microRNA that downregulates the expression of voltage-gated calcium channels. Upon placing a slice in a recording chamber and patching a CA1 neuron with a recording pipette, light pulses were used to stimulate the...
495
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

7.9K
Tissue-specific microRNA inhibition is a technology that is underdeveloped in the microRNA field. Herein, we describe a protocol to successfully inhibit the miR-181 microRNA family in myoblast cells from the heart. Nanovector technology is used to deliver a microRNA sponge that demonstrates significant in vivo cardio-specific miR-181 family...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long non-coding RNA triplex-dependent regulation of melanoma gene networks.

NAR genomics and bioinformatics·2026
Same author

Expanding Bevacizumab-Erlotinib Therapy Through Fumarate Hydratase Deficiency Screening and Drug Target Pathway Analysis in Papillary Morphology Metastatic Renal Cell Carcinoma.

European urology·2026
Same author

IQ-MPS Affiliate perspectives on blood-brain barrier microphysiological systems: Progress and challenges ahead.

ALTEX·2026
Same author

Targeted radioiodine therapy of ovarian cancer via the sodium/iodide symporter (NIS).

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

The tRNA Editing Complex ADAT2/3 Promotes Cancer Cell Growth and Codon-biased mRNA Translation.

Journal of molecular biology·2025
Same author

LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression.

Cell reports·2025

Related Experiment Video

Updated: Jan 19, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice.

Julia Ramirez-Moya1, León Wert-Lamas2, Adrián Acuña-Ruiz1

  • 1Instituto de Investigaciones Biomédicas, CSIC-UAM; Ciberonc, Instituto de Salud Carlos III.

Journal of Visualized Experiments : Jove
|September 10, 2019
PubMed
Summary

This study presents a method to test microRNA (miRNA) inhibitors as thyroid cancer therapy. Inhibiting specific miRNAs in mouse models reduced tumor growth, suggesting potential therapeutic applications.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.4K
Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo
09:48

Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo

Published on: March 29, 2014

14.4K

Related Experiment Videos

Last Updated: Jan 19, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.4K
Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo
09:48

Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo

Published on: March 29, 2014

14.4K

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) regulate gene expression and are implicated in cancer development.
  • Thyroid cancer involves genetic mutations and aberrant miRNA expression.
  • miRNAs are emerging as potential cancer biomarkers and therapeutic targets.

Purpose of the Study:

  • To present a protocol for evaluating miRNA-inhibitor delivery as a therapeutic strategy in thyroid cancer.
  • To assess the in vivo effects of miRNA inhibition on thyroid tumor growth and gene expression.
  • To identify novel therapeutic targets within miRNA pathways in thyroid cancer.

Main Methods:

  • Development of stable, bioluminescent thyroid cancer cell lines (GFP and luciferase expression).
  • Establishment of human tumor xenograft and orthotopic mouse models for thyroid cancer.
  • In vivo administration of miRNA inhibitors to assess therapeutic effects.

Main Results:

  • In vivo inhibition of specific miRNAs led to reduced tumor growth in mouse models.
  • Upregulation of miRNA gene targets was observed following miRNA inhibition.
  • The protocol allows for in vivo assessment of miRNA importance and therapeutic target identification.

Conclusions:

  • miRNA-inhibitor delivery shows promise as a therapeutic modality for thyroid cancer.
  • This methodology enables the evaluation of miRNA's role in thyroid tumorigenesis.
  • The study provides a framework for discovering new therapeutic targets in thyroid cancer.